Gastroesophageal reflux, Barrett esophagus, and esophageal cancer - Clinical applications

被引:59
作者
Shaheen, N
Ransohoff, DF
机构
[1] Univ N Carolina, Div Digest Dis & Nutr, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 15期
关键词
D O I
10.1001/jama.287.15.1982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastroesophageal reflux disease (GERD), a condition commonly encountered in the primary care setting, is a risk factor for adenocarcinoma of the esophagus. Despite the ubiquity of the complaint, considerable uncertainty exists with respect to several basic questions, including when to perform endoscopy in patients with chronic reflux symptoms and how to address the cancer risk associated with GERD. These clinical vignettes illustrate common clinical questions encountered in caring for patients with GERD, especially as they relate to the issue of cancer risk. Applying data reviewed in the companion article, we propose practical answers to common clinical situations regarding care of patients with reflux. We also present an algorithm for treatment of patients with chronic GERD symptoms.
引用
收藏
页码:1982 / 1986
页数:5
相关论文
共 43 条
[1]   APPROPRIATENESS OF INDICATIONS FOR DIAGNOSTIC UPPER GASTROINTESTINAL ENDOSCOPY - ASSOCIATION WITH RELEVANT ENDOSCOPIC DISEASE [J].
ADANG, RP ;
VISMANS, JFJFE ;
TALMON, JL ;
HASMAN, A ;
AMBERGEN, AW ;
STOCKBRUGER, RW .
GASTROINTESTINAL ENDOSCOPY, 1995, 42 (05) :390-397
[2]   RESULTS FROM THE AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY UNITED-STATES FOOD AND DRUG ADMINISTRATION COLLABORATIVE STUDY ON COMPLICATION RATES AND DRUG-USE DURING GASTROINTESTINAL ENDOSCOPY [J].
ARROWSMITH, JB ;
GERSTMAN, BB ;
FLEISCHER, DE ;
BENJAMIN, SB .
GASTROINTESTINAL ENDOSCOPY, 1991, 37 (04) :421-427
[3]  
Bloomston M, 1998, AM SURGEON, V64, P509
[4]   RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[5]  
Chan M F, 1996, Gastrointest Endosc Clin N Am, V6, P287
[6]   THE RELATION OF GASTROESOPHAGEAL REFLUX DISEASE AND ITS TREATMENT TO ADENOCARCINOMAS OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
CHOW, WH ;
FINKLE, WD ;
MCLAUGHLIN, JK ;
FRANKL, H ;
ZIEL, HK ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (06) :474-477
[7]   Conversions and complications of laparoscopic treatment of gastroesophageal reflux disease [J].
Coelho, JCU ;
Wiederkehr, JC ;
Campos, ACL ;
Andriguero, PC .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (04) :356-361
[8]  
DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434
[9]  
Eisen GM, 1997, AM J GASTROENTEROL, V92, P27
[10]   Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer [J].
Farrow, DC ;
Vaughan, TL ;
Sweeney, C ;
Gammon, MD ;
Chow, WH ;
Risch, HA ;
Stanford, JL ;
Hansten, PD ;
Mayne, ST ;
Schoenberg, JB ;
Rotterdam, H ;
Ahsan, H ;
West, AB ;
Dubrow, R ;
Fraumeni, JF ;
Blot, WJ .
CANCER CAUSES & CONTROL, 2000, 11 (03) :231-238